{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:37:15Z","timestamp":1770043035295,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.bcmd.2006.07.002","type":"journal-article","created":{"date-parts":[[2006,9,8]],"date-time":"2006-09-08T15:52:19Z","timestamp":1157730739000},"page":"197-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["RNAi-mediated inhibition of the glucosylceramide synthase (GCS) gene: A preliminary study towards a therapeutic strategy for Gaucher disease and other glycosphingolipid storage diseases"],"prefix":"10.1016","volume":"37","author":[{"given":"Anna","family":"Diaz-Font","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Chab\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00efsa","family":"Vilageliu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2006.07.002_bib1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood.V78.5.1183.1183","article-title":"Enzyme replacement therapy for Gaucher disease","volume":"78","author":"Beutler","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2006.07.002_bib2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2006.07.002_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1517\/13543784.12.2.273","article-title":"Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1","volume":"12","author":"Pastores","year":"2003","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bcmd.2006.07.002_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.20504","article-title":"Guidance on the use of miglustat for treating patients with type 1 Gaucher disease","volume":"80","author":"Weinreb","year":"2005","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2006.07.002_bib5","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2006.07.002_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000088409","article-title":"The current status of gene therapy in autologous transplantation","volume":"114","author":"Becker","year":"2005","journal-title":"Acta Haematol."},{"key":"10.1016\/j.bcmd.2006.07.002_bib7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/sj.gt.3302092","article-title":"Gene therapy progress and prospects: gene therapy of lysosomal storage disorders","volume":"10","author":"Cheng","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.bcmd.2006.07.002_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1079-9796(03)00157-8","article-title":"Unsuccessful chimeraplast strategy for the correction of a mutation causing Gaucher disease","volume":"31","author":"Diaz-Font","year":"2003","journal-title":"Blood Cells, Mol. Dis."},{"key":"10.1016\/j.bcmd.2006.07.002_bib9","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1016\/j.febslet.2005.08.004","article-title":"The therapeutic potential of RNA interference","volume":"579","author":"Uprichard","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcmd.2006.07.002_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1046-2023(02)00023-3","article-title":"Analysis of gene function in somatic mammalian cells using small interfering RNAs","volume":"26","author":"Elbashir","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.bcmd.2006.07.002_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bcmd.2006.07.002_bib12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0003-9861(90)90657-K","article-title":"Glucosyceramide synthase of mouse kidney: further characterization with an improved assay method","volume":"283","author":"Shukla","year":"1990","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcmd.2006.07.002_bib13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1039\/B411473F","article-title":"New aminocyclitols as modulators of glucosylceramide metabolism","volume":"3","author":"Egido-Gab\u00e1s","year":"2005","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bcmd.2006.07.002_bib14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2006.07.002_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nrd1345","article-title":"siRNAs: applications in functional genomics and potential as therapeutics","volume":"3","author":"Dorsett","year":"2004","journal-title":"Nat. Rev., Drug Discov."},{"key":"10.1016\/j.bcmd.2006.07.002_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/viro.1997.8494","article-title":"The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases","volume":"231","author":"Lee","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.bcmd.2006.07.002_bib17","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2006.07.002_bib18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nbt0502-446","article-title":"Expanding small RNA interference","volume":"20","author":"Tuschl","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcmd.2006.07.002_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jmb.2005.03.011","article-title":"Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions","volume":"348","author":"Schubert","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcmd.2006.07.002_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nbt831","article-title":"Expression profiling reveals off-target gene regulation by RNAi","volume":"21","author":"Jackson","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcmd.2006.07.002_bib21","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1073\/pnas.1131959100","article-title":"Specificity of short interfering RNA determined through gene expression signatures","volume":"100","author":"Semizarov","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2006.07.002_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1677\/jme.1.01582","article-title":"RNA interference and the use of small interfering RNA to study gene function in mammalian systems","volume":"33","author":"Bantounas","year":"2004","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bcmd.2006.07.002_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1602\/neurorx.2.1.139","article-title":"RNA interference and nonviral targeted gene therapy of experimental brain cancer","volume":"2","author":"Boado","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.bcmd.2006.07.002_bib24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.gt.3302661","article-title":"RNAi therapeutics: SNALPing siRNAs in vivo","volume":"13","author":"Rossi","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.bcmd.2006.07.002_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/154545703322617069","article-title":"Long endogenous dsRNAs can induce complete gene silencing in mammalian cells and primary cultures","volume":"13","author":"Diallo","year":"2003","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.bcmd.2006.07.002_bib26","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1073\/pnas.96.16.9142","article-title":"A vital role for glycosphingolipid synthesis during development and differentiation","volume":"96","author":"Yamashita","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2006.07.002_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.pharmthera.2005.08.006","article-title":"Interfering with the brain: use of RNA interference for understanding the pathophysiology of psychiatric and neurological disorders","volume":"109","author":"Thakker","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcmd.2006.07.002_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nm0305-243","article-title":"A crucial test","volume":"11","author":"Check","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2006.07.002_bib29","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S1359-6446(05)03547-6","article-title":"First clinical data on RNAi","volume":"10","author":"Whelan","year":"2005","journal-title":"Drug Discovery Today"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979606001604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979606001604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:22:48Z","timestamp":1761049368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979606001604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1079979606001604"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2006.07.002","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNAi-mediated inhibition of the glucosylceramide synthase (GCS) gene: A preliminary study towards a therapeutic strategy for Gaucher disease and other glycosphingolipid storage diseases","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2006.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}